Brief: Anygen signs contract worth 921.1 mln won
Feb 14 (Reuters) - Anygen Co Ltd 196300.KQ :
* Says it signed a 921.1 million won contract with Cytlimic
Inc to provide research and service of GPC-3 and HSP-70 process
development in Japan
Source text in Korean: https://goo.gl/PZ6mnQ
Further company coverage: 196300.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on HLB Pep
See all newsBrief: Hlb Pep To Acquire Real Estate Worth 3 Billion Won From Korea Advanced Materials Co Ltd
Brief: S.Korea's Anygen Says Acquires Patent For Breast Cancer Therapeutic Agent In Japan
Brief: Anygen issues 2nd tranche convertible bonds worth 15 bln won
Brief: Anygen to issue 2nd series convertible bonds worth 15 bln won
Brief: Anygen to buy facilities for 9.17 bln won